PDF herunterladen
Semin Reprod Med 2017; 35(04): 344-352
DOI: 10.1055/s-0037-1606384
Review Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

The Effects of Aspirin in Gestation and Reproduction (EAGeR) Trial: A Story of Discovery

Matthew T. Connell
1   Division of Intramural Population Health Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland
2   Program of Reproductive and Adult Endocrinology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland
,
Lindsey A. Sjaarda
1   Division of Intramural Population Health Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland
,
Rose G. Radin
1   Division of Intramural Population Health Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland
,
Daniel Kuhr
1   Division of Intramural Population Health Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland
,
Sunni L. Mumford
1   Division of Intramural Population Health Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland
,
Torie C. Plowden
1   Division of Intramural Population Health Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland
2   Program of Reproductive and Adult Endocrinology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland
,
Robert M. Silver
3   Department of Obstetrics and Gynecology, University of Utah and Intermountain Healthcare, Salt Lake City, Utah
,
Enrique F. Schisterman
1   Division of Intramural Population Health Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland
› Institutsangaben
Weitere Informationen

Publikationsverlauf

Publikationsdatum:
16. Oktober 2017 (online)

    Lizenzen und Reprints

Abstract

Human reproduction is an inefficient process. There are several drivers of complications along the path to and during pregnancy, one of which is inflammation. Treatments to mitigate the deleterious effects of aberrant inflammation with something inexpensive and widely available like aspirin could have dramatic global impact. The Effects of Aspirin in Gestation and Reproduction (EAGeR) trial enrolled women aged 18 to 40 years with one to two prior pregnancy losses and no diagnosis of infertility. Patients were randomized to either low-dose aspirin or placebo. Here, we review the collective findings of the EAGeR trial to date and discuss several important lessons learned from the unique data resulting from this groundbreaking trial. Findings reported from this trial provide significant advances in the understanding of aspirin's potential mechanisms in modulating reproductive processes and the role of inflammation in these processes. This review describes the collective findings of the EAGeR trial in the context of the existing literature regarding aspirin and inflammation in reproduction to inform relevant next steps in fertility and obstetric research, as well as potential implications for clinical care.

Keywords

aspirin - inflammation - implantation

Trial Registration

ClinicalTrials.gov, NCT00467363.


Funding

This study was funded by the Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD (contract nos. HHSN267200603423, HHSN267200603424, and HHSN 267200603426) and by the National Institutes of Health (NIH) Medical Research Scholars Program, a public–private partnership supported jointly by the NIH and generous contributions to the Foundation for the NIH from the Doris Duke Charitable Foundation, the American Association for Dental Research, the Colgate-Palmolive Company, Genentech, and alumni of student research programs and other individual supporters via contributions to the Foundation for the National Institutes of Health.


 

  • References

  • 1 Zinaman MJ, Clegg ED, Brown CC, O'Connor J, Selevan SG. Estimates of human fertility and pregnancy loss. Fertil Steril 1996; 65 (03) 503-509
    CrossrefPubMedGoogle Scholar
  • 2 Wilcox AJ, Weinberg CR, O'Connor JF. , et al. Incidence of early loss of pregnancy. N Engl J Med 1988; 319 (04) 189-194
    CrossrefPubMedGoogle Scholar
  • 3 Guttmacher AF. Factors affecting normal expectancy of conception. J Am Med Assoc 1956; 161 (09) 855-860
    CrossrefPubMedGoogle Scholar
  • 4 Wilcox AJ, Baird DD, Weinberg CR. Time of implantation of the conceptus and loss of pregnancy. N Engl J Med 1999; 340 (23) 1796-1799
    CrossrefPubMedGoogle Scholar
  • 5 Risch HA, Weiss NS, Clarke EA, Miller AB. Risk factors for spontaneous abortion and its recurrence. Am J Epidemiol 1988; 128 (02) 420-430
    CrossrefPubMedGoogle Scholar
  • 6 Eiben B, Bartels I, Bähr-Porsch S. , et al. Cytogenetic analysis of 750 spontaneous abortions with the direct-preparation method of chorionic villi and its implications for studying genetic causes of pregnancy wastage. Am J Hum Genet 1990; 47 (04) 656-663
    PubMedGoogle Scholar
  • 7 Acién P. Reproductive performance of women with uterine malformations. Hum Reprod 1993; 8 (01) 122-126
    CrossrefPubMedGoogle Scholar
  • 8 Committee on Practice Bulletins—Obstetrics, American College of Obstetricians and Gynecologists. Practice Bulletin No. 132: Antiphospholipid syndrome. Obstet Gynecol 2012; 120 (06) 1514-1521
    CrossrefPubMedGoogle Scholar
  • 9 Abalovich M, Gutierrez S, Alcaraz G, Maccallini G, Garcia A, Levalle O. Overt and subclinical hypothyroidism complicating pregnancy. Thyroid 2002; 12 (01) 63-68
    CrossrefPubMedGoogle Scholar
  • 10 Greene MF. Spontaneous abortions and major malformations in women with diabetes mellitus. Semin Reprod Endocrinol 1999; 17 (02) 127-136
    Artikel in Thieme ConnectPubMedGoogle Scholar
  • 11 Silver RM, Branch DW. Sporadic and recurrent pregnancy loss. In: Reece EA, Hobbins JC. , eds. Medicine of the Fetus and Mother. 2nd ed. Philadelphia, PA: JB Lippincott Company; 1999: 195-216
    Google Scholar
  • 12 Mor G, Cardenas I, Abrahams V, Guller S. Inflammation and pregnancy: the role of the immune system at the implantation site. Ann N Y Acad Sci 2011; 1221: 80-87
    CrossrefPubMedGoogle Scholar
  • 13 Romero R, Dey SK, Fisher SJ. Preterm labor: one syndrome, many causes. Science 2014; 345 (6198): 760-765
    CrossrefPubMedGoogle Scholar
  • 14 Kalagiri RR, Carder T, Choudhury S. , et al. Inflammation in complicated pregnancy and its outcome. Am J Perinatol 2016; 33 (14) 1337-1356
    Artikel in Thieme ConnectPubMedGoogle Scholar
  • 15 Bossick AS, Peters RM, Burmeister C, Kakumanu N, Shill JE, Cassidy-Bushrow AE. Antenatal inflammation and gestational diabetes mellitus risk among pregnant African-American women. J Reprod Immunol 2016; 115: 1-5
    CrossrefPubMedGoogle Scholar
  • 16 Thilaganathan B, Wormald B, Zanardini C, Sheldon J, Ralph E, Papageorghiou AT. Early-pregnancy multiple serum markers and second-trimester uterine artery Doppler in predicting preeclampsia. Obstet Gynecol 2010; 115 (06) 1233-1238
    CrossrefPubMedGoogle Scholar
  • 17 Boots CE, Jungheim ES. Inflammation and human ovarian follicular dynamics. Semin Reprod Med 2015; 33 (04) 270-275
    Artikel in Thieme ConnectPubMedGoogle Scholar
  • 18 Reljic M, Gorisek B. C-reactive protein and the treatment of pelvic inflammatory disease. Int J Gynaecol Obstet 1998; 60 (02) 143-150
    CrossrefPubMedGoogle Scholar
  • 19 Escobar-Morreale HF, Luque-Ramírez M, González F. Circulating inflammatory markers in polycystic ovary syndrome: a systematic review and metaanalysis. Fertil Steril 2011; 95 (03) 1048-58.e1 , 2
    CrossrefPubMedGoogle Scholar
  • 20 Agic A, Xu H, Finas D, Banz C, Diedrich K, Hornung D. Is endometriosis associated with systemic subclinical inflammation?. Gynecol Obstet Invest 2006; 62 (03) 139-147
    CrossrefPubMedGoogle Scholar
  • 21 Vane JR, Botting RM. The mechanism of action of aspirin. Thromb Res 2003; 110 (5-6): 255-258
    CrossrefPubMedGoogle Scholar
  • 22 Rubinstein M, Marazzi A, Polak de Fried E. Low-dose aspirin treatment improves ovarian responsiveness, uterine and ovarian blood flow velocity, implantation, and pregnancy rates in patients undergoing in vitro fertilization: a prospective, randomized, double-blind placebo-controlled assay. Fertil Steril 1999; 71 (05) 825-829
    CrossrefPubMedGoogle Scholar
  • 23 Dentali F, Ageno W, Rezoagli E. , et al. Low-dose aspirin for in vitro fertilization or intracytoplasmic sperm injection: a systematic review and a meta-analysis of the literature. J Thromb Haemost 2012; 10 (10) 2075-2085
    CrossrefPubMedGoogle Scholar
  • 24 Kaandorp SP, Goddijn M, van der Post JA. , et al. Aspirin plus heparin or aspirin alone in women with recurrent miscarriage. N Engl J Med 2010; 362 (17) 1586-1596
    CrossrefPubMedGoogle Scholar
  • 25 Kaandorp S, Di Nisio M, Goddijn M, Middeldorp S. Aspirin or anticoagulants for treating recurrent miscarriage in women without antiphospholipid syndrome. Cochrane Database Syst Rev 2009; (01) CD004734
    PubMedGoogle Scholar
  • 26 Tulppala M, Marttunen M, Söderstrom-Anttila V. , et al. Low-dose aspirin in prevention of miscarriage in women with unexplained or autoimmune related recurrent miscarriage: effect on prostacyclin and thromboxane A2 production. Hum Reprod 1997; 12 (07) 1567-1572
    CrossrefPubMedGoogle Scholar
  • 27 Badawy AM, Khiary M, Sherif LS, Hassan M, Ragab A, Abdelall I. Low-molecular weight heparin in patients with recurrent early miscarriages of unknown aetiology. J Obstet Gynaecol 2008; 28 (03) 280-284
    CrossrefPubMedGoogle Scholar
  • 28 Clark P, Walker ID, Langhorne P. , et al; Scottish Pregnancy Intervention Study (SPIN) collaborators. SPIN (Scottish Pregnancy Intervention) study: a multicenter, randomized controlled trial of low-molecular-weight heparin and low-dose aspirin in women with recurrent miscarriage. Blood 2010; 115 (21) 4162-4167
    CrossrefPubMedGoogle Scholar
  • 29 Dolitzky M, Inbal A, Segal Y, Weiss A, Brenner B, Carp H. A randomized study of thromboprophylaxis in women with unexplained consecutive recurrent miscarriages. Fertil Steril 2006; 86 (02) 362-366
    CrossrefPubMedGoogle Scholar
  • 30 Visser J, Ulander VM, Helmerhorst FM. , et al. Thromboprophylaxis for recurrent miscarriage in women with or without thrombophilia. HABENOX: a randomised multicentre trial. Thromb Haemost 2011; 105 (02) 295-301
    Artikel in Thieme ConnectPubMedGoogle Scholar
  • 31 Dirckx K, Cabri P, Merien A. , et al. Does low-dose aspirin improve pregnancy rate in IVF/ICSI? A randomized double-blind placebo controlled trial. Hum Reprod 2009; 24 (04) 856-860
    PubMedGoogle Scholar
  • 32 Duvan CI, Ozmen B, Satiroglu H, Atabekoglu CS, Berker B. Does addition of low-dose aspirin and/or steroid as a standard treatment in nonselected intracytoplasmic sperm injection cycles improve in vitro fertilization success? A randomized, prospective, placebo-controlled study. J Assist Reprod Genet 2006; 23 (01) 15-21
    CrossrefPubMedGoogle Scholar
  • 33 Lambers MJ, Hoozemans DA, Schats R, Homburg R, Lambalk CB, Hompes PG. Low-dose aspirin in non-tubal IVF patients with previous failed conception: a prospective randomized double-blind placebo-controlled trial. Fertil Steril 2009; 92 (03) 923-929
    CrossrefPubMedGoogle Scholar
  • 34 LeFevre ML. ; U.S. Preventive Services Task Force. Low-dose aspirin use for the prevention of morbidity and mortality from preeclampsia: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2014; 161 (11) 819-826
    CrossrefPubMedGoogle Scholar
  • 35 Schisterman EF, Silver RM, Lesher LL. , et al. Preconception low-dose aspirin and pregnancy outcomes: results from the EAGeR randomised trial. Lancet 2014; 384 (9937): 29-36
    CrossrefPubMedGoogle Scholar
  • 36 Mumford SL, Silver RM, Sjaarda LA. , et al. Expanded findings from a randomized controlled trial of preconception low-dose aspirin and pregnancy loss. Hum Reprod 2016; 31 (03) 657-665
    PubMedGoogle Scholar
  • 37 Schisterman EF, Mumford SL, Schliep KC. , et al. Preconception low dose aspirin and time to pregnancy: findings from the effects of aspirin in gestation and reproduction randomized trial. J Clin Endocrinol Metab 2015; 100 (05) 1785-1791
    CrossrefPubMedGoogle Scholar
  • 38 Haiman CA, Pike MC, Bernstein L. , et al. Ethnic differences in ovulatory function in nulliparous women. Br J Cancer 2002; 86 (03) 367-371
    CrossrefPubMedGoogle Scholar
  • 39 Malcolm CE, Cumming DC. Does anovulation exist in eumenorrheic women?. Obstet Gynecol 2003; 102 (02) 317-318
    PubMedGoogle Scholar
  • 40 Park SJ, Goldsmith LT, Skurnick JH, Wojtczuk A, Weiss G. Characteristics of the urinary luteinizing hormone surge in young ovulatory women. Fertil Steril 2007; 88 (03) 684-690
    CrossrefPubMedGoogle Scholar
  • 41 Gaskins AJ, Mumford SL, Zhang C. , et al; BioCycle Study Group. Effect of daily fiber intake on reproductive function: the BioCycle Study. Am J Clin Nutr 2009; 90 (04) 1061-1069
    CrossrefPubMedGoogle Scholar
  • 42 Marsh EE, Shaw ND, Klingman KM. , et al. Estrogen levels are higher across the menstrual cycle in African-American women compared with Caucasian women. J Clin Endocrinol Metab 2011; 96 (10) 3199-3206
    CrossrefPubMedGoogle Scholar
  • 43 Matyas RA, Mumford SL, Schliep KC. , et al. Effects of over-the-counter analgesic use on reproductive hormones and ovulation in healthy, premenopausal women. Hum Reprod 2015; 30 (07) 1714-1723
    CrossrefPubMedGoogle Scholar
  • 44 Nargund G, Wei CC. Successful planned delay of ovulation for one week with indomethacin. J Assist Reprod Genet 1996; 13 (08) 683-684
    CrossrefPubMedGoogle Scholar
  • 45 Radin RG, Sjaarda LA, Perkins NJ. , et al. Low-dose aspirin and sporadic anovulation in the EAGeR randomized trial. J Clin Endocrinol Metab 2017; 102 (01) 86-92
    PubMedGoogle Scholar
  • 46 Sjaarda LA, Radin RG, Silver RM. , et al. Preconception low-dose aspirin restores diminished pregnancy and live birth rates in women with low grade inflammation: a secondary analysis of a randomized trial. J Clin Endocrinol Metab 2017; 102 (05) 1495-1504
    CrossrefPubMedGoogle Scholar
  • 47 Wolowczuk I. Obesity – an inflammatory state. Acta Vet Scand 2015; 57 (Suppl. 01) K5-K5
    CrossrefPubMedGoogle Scholar
  • 48 Macklon NS, Brosens JJ. The human endometrium as a sensor of embryo quality. Biol Reprod 2014; 91 (04) 98
    PubMedGoogle Scholar
  • 49 Bermejo-Alvarez P, Rizos D, Rath D, Lonergan P, Gutierrez-Adan A. Sex determines the expression level of one third of the actively expressed genes in bovine blastocysts. Proc Natl Acad Sci U S A 2010; 107 (08) 3394-3399
    CrossrefPubMedGoogle Scholar
  • 50 Gardner DK, Larman MG, Thouas GA. Sex-related physiology of the preimplantation embryo. Mol Hum Reprod 2010; 16 (08) 539-547
    CrossrefPubMedGoogle Scholar
  • 51 Pérez-Crespo M, Ramírez MA, Fernández-González R. , et al. Differential sensitivity of male and female mouse embryos to oxidative induced heat-stress is mediated by glucose-6-phosphate dehydrogenase gene expression. Mol Reprod Dev 2005; 72 (04) 502-510
    CrossrefPubMedGoogle Scholar
  • 52 Dobbs KB, Gagné D, Fournier E. , et al. Sexual dimorphism in developmental programming of the bovine preimplantation embryo caused by colony-stimulating factor 2. Biol Reprod 2014; 91 (03) 80
    PubMedGoogle Scholar
  • 53 Allan BB, Brant R, Seidel JE, Jarrell JF. Declining sex ratios in Canada. CMAJ 1997; 156 (01) 37-41
    PubMedGoogle Scholar
  • 54 Mathews TJ, Hamilton BE. Trend analysis of the sex ratio at birth in the United States. Natl Vital Stat Rep 2005; 53 (20) 1-17
    PubMedGoogle Scholar
  • 55 Davis DL, Gottlieb MB, Stampnitzky JR. Reduced ratio of male to female births in several industrial countries: a sentinel health indicator?. JAMA 1998; 279 (13) 1018-1023
    CrossrefPubMedGoogle Scholar
  • 56 Møller H. Change in male:female ratio among newborn infants in Denmark. Lancet 1996; 348 (9030): 828-829
    PubMedGoogle Scholar
  • 57 Parazzini F, La Vecchia C, Levi F, Franceschi S. Trends in male:female ratio among newborn infants in 29 countries from five continents. Hum Reprod 1998; 13 (05) 1394-1396
    CrossrefPubMedGoogle Scholar
  • 58 Fukuda M, Fukuda K, Shimizu T, Andersen CY, Byskov AG. Parental periconceptional smoking and male: female ratio of newborn infants. Lancet 2002; 359 (9315): 1407-1408
    CrossrefPubMedGoogle Scholar
  • 59 Mocarelli P, Gerthoux PM, Ferrari E. , et al. Paternal concentrations of dioxin and sex ratio of offspring. Lancet 2000; 355 (9218): 1858-1863
    CrossrefPubMedGoogle Scholar
  • 60 Hertz-Picciotto I. The evidence that lead increases the risk for spontaneous abortion. Am J Ind Med 2000; 38 (03) 300-309
    CrossrefPubMedGoogle Scholar
  • 61 Aschengrau A, Zierler S, Cohen A. Quality of community drinking water and the occurrence of spontaneous abortion. Arch Environ Health 1989; 44 (05) 283-290
    CrossrefPubMedGoogle Scholar
  • 62 Garry VF, Harkins M, Lyubimov A, Erickson L, Long L. Reproductive outcomes in the women of the Red River Valley of the north. I. The spouses of pesticide applicators: pregnancy loss, age at menarche, and exposures to pesticides. J Toxicol Environ Health A 2002; 65 (11) 769-786
    CrossrefPubMedGoogle Scholar
  • 63 Fukuda M, Fukuda K, Shimizu T, Møller H. Decline in sex ratio at birth after Kobe earthquake. Hum Reprod 1998; 13 (08) 2321-2322
    CrossrefPubMedGoogle Scholar
  • 64 Saadat M. Decline in sex ratio at birth after Bam (Kerman Province, Southern Iran) earthquake. J Biosoc Sci 2008; 40 (06) 935-937
    PubMedGoogle Scholar
  • 65 Radin RG, Mumford SL, Silver RM. , et al. Sex ratio following preconception low-dose aspirin in women with prior pregnancy loss. J Clin Invest 2015; 125 (09) 3619-3626
    CrossrefPubMedGoogle Scholar
  • 66 Anderson GD, Hauser SD, McGarity KL, Bremer ME, Isakson PC, Gregory SA. Selective inhibition of cyclooxygenase (COX)-2 reverses inflammation and expression of COX-2 and interleukin 6 in rat adjuvant arthritis. J Clin Invest 1996; 97 (11) 2672-2679
    CrossrefPubMedGoogle Scholar
  • 67 ACOG Practice Bulletin No 156: Obesity in pregnancy. Obstet Gynecol 2015; 126 (06) e112-e126
    CrossrefPubMedGoogle Scholar
  • 68 Gandevani SB, Banaem LM, Mohamadi B, Moghadam NA, Asghari M. Association of high-sensitivity C-reactive protein serum levels in early pregnancy with the severity of preeclampsia and fetal birth weight. J Perinat Med 2012; 40 (06) 601-605
    PubMedGoogle Scholar
  • 69 Mathews TJ, Menacker F, MacDorman MF. ; Centers for Disease Control and Prevention, National Center for Health Statistics. Infant mortality statistics from the 2002 period: linked birth/infant death data set. Natl Vital Stat Rep 2004; 53 (10) 1-29
    PubMedGoogle Scholar
  • 70 Anderson RN, Smith BL. Deaths: leading causes for 2001. Natl Vital Stat Rep 2003; 52 (09) 1-85
    PubMedGoogle Scholar
  • 71 Duley L, Henderson-Smart DJ, Meher S, King JF. Antiplatelet agents for preventing pre-eclampsia and its complications. Cochrane Database Syst Rev 2007; (02) CD004659
    PubMedGoogle Scholar
  • 72 Silver RM, Ahrens K, Wong LF. , et al. Low-dose aspirin and preterm birth: a randomized controlled trial. Obstet Gynecol 2015; 125 (04) 876-884
    CrossrefPubMedGoogle Scholar
  • 73 van Vliet EO, Askie LA, Mol BW, Oudijk MA. Antiplatelet agents and the prevention of spontaneous preterm birth: a systematic review and meta-analysis. Obstet Gynecol 2017; 129 (02) 327-336
    CrossrefPubMedGoogle Scholar
  • 74 MacIntyre DA, Sykes L, Teoh TG, Bennett PR. Prevention of preterm labour via the modulation of inflammatory pathways. J Matern Fetal Neonatal Med 2012; 25 (Suppl. 01) 17-20
    CrossrefPubMedGoogle Scholar
  • 75 Abramovici A, Cantu J, Jenkins SM. Tocolytic therapy for acute preterm labor. Obstet Gynecol Clin North Am 2012; 39 (01) 77-87
    CrossrefPubMedGoogle Scholar
  • 76 Lewis RB, Schulman JD. Influence of acetylsalicylic acid, an inhibitor of prostaglandin synthesis, on the duration of human gestation and labour. Lancet 1973; 2 (7839): 1159-1161
    PubMedGoogle Scholar
  • 77 Henderson JT, Whitlock EP, O'Connor E, Senger CA, Thompson JH, Rowland MG. Low-dose aspirin for prevention of morbidity and mortality from preeclampsia: a systematic evidence review for the U.S. Preventive Services Task Force. Ann Intern Med 2014; 160 (10) 695-703
    CrossrefPubMedGoogle Scholar
  • 78 American College of Obstetricians and Gynecologists; Task Force on Hypertension in Pregnancy. Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists' Task Force on Hypertension in Pregnancy. Obstet Gynecol 2013; 122 (05) 1122-1131
    CrossrefPubMedGoogle Scholar
  • 79 Ahrens KA, Silver RM, Mumford SL. , et al. Complications and safety of preconception low-dose aspirin among women with prior pregnancy losses. Obstet Gynecol 2016; 127 (04) 689-698
    PubMedGoogle Scholar
  • 80 Truong A, Sayago MM, Kutteh WH, Ke RW. Subchorionic hematomas are increased in early pregnancy in women taking low-dose aspirin. Fertil Steril 2016; 105 (05) 1241-1246
    CrossrefPubMedGoogle Scholar
  • 81 Nørgård B, Puhó E, Czeizel AE, Skriver MV, Sørensen HT. Aspirin use during early pregnancy and the risk of congenital abnormalities: a population-based case-control study. Am J Obstet Gynecol 2005; 192 (03) 922-923
    CrossrefPubMedGoogle Scholar
  • 82 Kozer E, Nikfar S, Costei A, Boskovic R, Nulman I, Koren G. Aspirin consumption during the first trimester of pregnancy and congenital anomalies: a meta-analysis. Am J Obstet Gynecol 2002; 187 (06) 1623-1630
    CrossrefPubMedGoogle Scholar